BioLineRx Ltd. (TLV:BLRX)
2.300
0.00 (0.00%)
Oct 5, 2025, 1:37 PM IDT
BioLineRx Revenue
BioLineRx had revenue of $304.00K USD in the quarter ending June 30, 2025, a decrease of -94.36%. This brings the company's revenue in the last twelve months to $17.25M, up 1.19% year-over-year. In the year 2024, BioLineRx had annual revenue of $28.94M with 502.92% growth.
Revenue (ttm)
$17.25M
Revenue Growth
+1.19%
P/S Ratio
1.03
Revenue / Employee
$616.11K
Employees
28
Market Cap
60.05M ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 28.94M | 24.14M | 502.92% |
Dec 31, 2023 | 4.80M | - | - |
Dec 31, 2022 | - | - | - |
Dec 31, 2021 | - | - | - |
Dec 31, 2020 | - | - | - |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Teva Pharmaceutical Industries | 56.02B |
Danel (Adir Yeoshua) | 2.84B |
Kamada | 571.15M |
Bait Bakfar | 106.25M |
BrainsWay | 155.27M |
SofWave Medical | 234.12M |
Ilex Medical | 927.57M |
Novolog (Pharm-Up 1966) | 2.04B |
BioLineRx News
- 8 days ago - BioLineRx Ltd. (BLRX) Investor Call (Transcript) - Seeking Alpha
- 8 days ago - BioLineRx Ltd. - Special Call - Seeking Alpha
- 8 days ago - BioLineRx (BLRX) and Hemispherian Collaborate on Innovative Cancer Therapy - GuruFocus
- 8 days ago - BioLineRx Ltd. and Hemispherian AS Establish Joint Venture to Develop GLIX1, a First-in-Class, Oral, Small Molecule Targeting DNA Damage Response in Glioblastoma and Other Cancers - PRNewsWire
- 7 weeks ago - BioLineRx Ltd. (BLRX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - BioLineRx GAAP EPS of $0.00, revenue of $5.39M - Seeking Alpha
- 7 weeks ago - BioLineRx Reports Second Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 7 weeks ago - Earnings Scheduled For August 14, 2025 - Benzinga